Evidence map›Paper›PMID 35459681›Full record

ArticleBMJ open2022

Intercountry and intracountry variations in opinions of palliative care specialist physicians in Germany, Italy, Japan and UK about continuous use of sedatives: an international cross-sectional survey.

Tatsuya Morita, Takuya Kawahara, Patrick Stone, Nigel Sykes, Guido Miccinesi, Carsten Klein, Stephanie Stiel, David Hui, Luc Deliens, Madelon T Heijltjes and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 7 countries.

Tatsuya MoritaPalliative and Supportive Care Division, Seirei Mikatahara Hospital, Hamamatsu, Shizuoka, Japan tmorita@sis.seirei.or.jp.ORCID 0000-0002-7257-7429
Takuya KawaharaClinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
Patrick StoneMarie Curie Palliative Care Research Department, Division of Psychiatry, University College London, London, UK.
Nigel SykesMarie Curie Palliative Care Research Department, Division of Psychiatry, University College London, London, UK.
Guido MiccinesiDepartment of Oncological Network, Prevention and Research Institute-ISPRO, Firenze, Italy.
Carsten KleinDepartment of Palliative Medicine, CCC Erlangen - EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Nürnberg, Germany.
Stephanie StielInstitute for General Practice and Palliative Care, Hannover Medical School, Hannover, Germany.
David HuiDepartment of Palliative Care and Rehabilitation Medicine, MD Anderson Cancer Center, University of Texas, Austin, Texas, USA.
Luc DeliensEnd-of-Life Care Research Group, Vrije Universiteit Brussel, Brussels, Belgium.
Madelon T HeijltjesJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Masanori MoriPalliative and Supportive care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Maria HeckelDepartment of Palliative Medicine, CCC Erlangen - EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Lenzo RobijnDepartment of Public Health and Primary Care, Ghent University, Ghent, Belgium.
Lalit KrishnaThe Division of Supportive and Palliative Care, National Cancer Center Singapore, National Cancer Center Singapore, Singapore.
Judith RietjensDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity College London · GBErasmus MC · NLGhent University · BEMedizinische Hochschule Hannover · DENational Cancer Centre Singapore · SGSeirei Mikatabara General Hospital · JPSeirei Social Welfare Community · JPThe University of Texas MD Anderson Cancer Center · USUniversity Medical Center Utrecht · NLUniversity of Tokyo Hospital · JPVrije Universiteit Brussel · BE

Funding

Marie Curie MCCC-FCH-18-U
6 · The paper itself

Abstract

objectivesTo explore intercountry and intracountry differences in physician opinions about continuous use of sedatives (CUS), and factors associated with their approval of CUS. SETTINGS: Secondary analysis of a questionnaire study.

participantsPalliative care physicians in Germany (N=273), Italy (N=198), Japan (N=334) and the UK (N=111). PRIMARY AND SECONDARY OUTCOME MEASURES: Physician approval for CUS in four situations, intention and treatment goal, how to use sedatives and beliefs about CUS.

resultsThere were no significant intercountry or intracountry differences in the degree of agreement with statements that (1) CUS is not necessary as suffering can always be relieved with other measures (mostly disagree); (2) intention of CUS is to alleviate suffering and (3) shortening the dying process is not intended. However, there were significant intercountry differences in agreement with statements that (1) CUS is acceptable for patients with longer survival or psychoexistential suffering; (2) decrease in consciousness is intended and (3) choice of neuroleptics or opioids. Acceptability of CUS for patients with longer survival or psychoexistential suffering and whether decrease in consciousness is intended also showed wide intracountry differences. Also, the proportion of physicians who agreed versus disagreed with the statement that CUS may not alleviate suffering adequately even in unresponsive patients, was approximately equal. Regression analyses revealed that both physician-related and country-related factors were independently associated with physicians' approval of CUS.

conclusionVariations in use of sedatives is due to both physician- and country-related factors, but palliative care physicians consistently agree on the value of sedatives to aid symptom control. Future research should focus on (1) whether sedatives should be used in patients with longer survival or with primarily psychoexistential suffering, (2) understanding physicians' intentions and treatment goals, (3) efficacy of different drugs and (4) understanding the actual experiences of patients receiving CUS.

Indexed as

PhysiciansTerminal CareCross-Sectional StudiesGermanyHumansHypnotics and SedativesJapanPalliative CareSurveys and QuestionnairesUnited KingdomHypnotics and Sedativesadult palliative caremedical ethicspalliative care

Identifiers

PMID35459681
PMCPMC9036469
OpenAlexW4224308952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.